# Repaglinide

NDC: 33342-248
Generic name: Repaglinide
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20230322

FDA application: ANDA207209

## Active ingredients

- REPAGLINIDE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-248"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-248
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7a93246c-9323-40c4-b590-a40dcb133c8c